Vetter Pharma began construction in December of 2017 on its United States headquarters in Des Plains, Ill. The $350 million project includes renovation of an existing five-story office building and construction of four new facilities providing over 700,000 sf of pharmaceutical manufacturing and warehousing space. Commercial production is expected to begin at the site by 2022. A second phase of construction comprising two additional buildings will reach completion by 2025. Vetter Pharma is based in Ravensburg, Germany.